10-Q · June 25, 2026
McCormick & Company reported strong Q2 2026 results with net sales of $1.937 billion, reflecting a notable 16.7% increase year-over-year. The operating income rose to $276.4 million, a 12.4% improvement compared to the…
Earnings analysis · 10-Q
Filed October 1, 2026 · Our reading of the company's report
The latest report
McCormick delivered Q3 revenue of $2.025 billion and adjusted EPS of $0.86, beating consensus by 2.3% and 14.7%, respectively, with growth supported by the McCormick de Mexico acquisition, organic sales growth, and…
McCormick delivered Q3 revenue of $2.025 billion and adjusted EPS of $0.86, beating consensus by 2.3% and 14.7%, respectively, with growth supported by the McCormick de Mexico acquisition, organic sales growth, and margin expansion. GAAP EPS was only $0.36 because of $141.5 million of special charges, limiting the quality of the quarter’s earnings beat. The filing also adds material risks tied to the proposed Unilever transaction, including completion uncertainty, expected leverage, integration execution, and dilution, while fiscal 2026 outlook was reaffirmed in the earnings release.
Q3 revenue was $2.025 billion, up from $1.94 billion in Q2 2026 and $1.72 billion in Q3 2025, representing sequential growth of approximately 4.4% and year-over-year growth of approximately 17.7%.
Adjusted EPS was $0.86 versus the $0.75 consensus estimate, a 14.7% beat; GAAP EPS was $0.36 after $141.5 million of special charges.
The company had $403 million remaining under its $600 million share repurchase authorization as of August 31, 2026, providing continued capital-allocation flexibility.
Management concluded that disclosure controls were effective as of the quarter end, and reported no changes in internal control over financial reporting that materially affected, or were reasonably likely to materially affect, controls.
The filing newly identifies Middle East geopolitical instability as a risk, citing disruption to global oil and gas flows and potential increases in energy and freight costs; management stated it expects the conflict’s impacts to continue affecting the business but cannot predict their extent.
The proposed Unilever transaction remains subject to shareholder approval, Hart-Scott-Rodino clearance, other regulatory approvals, and an effective Form S-4 registration statement, leaving timing and completion uncertain.
The company expects substantial transaction-related debt and may need to draw on the Bridge Facility if permanent financing is unavailable; the filing warns that higher debt could increase interest expense and reduce cash available for operations and capital expenditures.
Existing McCormick shareholders are expected to own approximately 35.0% of the combined company, versus approximately 55.1% for current Unilever shareholders and up to 9.9% retained by Unilever, creating substantial dilution and reduced voting influence.
The filing warns that integration may require additional cash and incur costs beyond expectations, while the transaction is expected to substantially expand the business and increase competition across product categories and regions.
The 10-Q does not provide numeric guidance in the extracted MD&A. Fiscal 2026 outlook was reaffirmed in the October 1, 2026 earnings release at net sales growth of 13% to 17%, adjusted operating income growth of 16% to 20%, and adjusted EPS growth of 2% to 5%.
McCormick & Company reported strong Q2 2026 results with net sales of $1.937 billion, reflecting a notable 16.7% increase year-over-year. The operating income rose to $276.4 million, a 12.4% improvement compared to the…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.